🇺🇸 FDA
Pipeline program

FLUOROURACIL, Tecentriq 1 200 mg concentrate for solution for infusion, CALCIUM FOLINATE PENTAHYDRATE, OXALIPLATIN

A021502

Phase 3 small_molecule active

Quick answer

FLUOROURACIL, Tecentriq 1 200 mg concentrate for solution for infusion, CALCIUM FOLINATE PENTAHYDRATE, OXALIPLATIN for stage III colon adenocarcinoma with deficient MMR is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
stage III colon adenocarcinoma with deficient MMR
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials